Skip to main navigation Skip to search Skip to main content

Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status

  • Haoshen Shi
  • , Nazanin Mirzaei
  • , Yosef Koronyo
  • , Miyah R. Davis
  • , Edward Robinson
  • , Gila M. Braun
  • , Ousman Jallow
  • , Altan Rentsendorj
  • , V. Krishnan Ramanujan
  • , Justyna Fert-Bober
  • , Andrei A. Kramerov
  • , Alexander V. Ljubimov
  • , Lon S. Schneider
  • , Warren G. Tourtellotte
  • , Debra Hawes
  • , Julie A. Schneider
  • , Keith L. Black
  • , Rakez Kayed
  • , Maj Linda B. Selenica
  • , Daniel C. Lee
  • Dieu Trang Fuchs, Maya Koronyo-Hamaoui

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

This study investigates various pathological tau isoforms in the retina of individuals with early and advanced Alzheimer’s disease (AD), exploring their connection with disease status. Retinal cross-sections from predefined superior-temporal and inferior-temporal subregions and corresponding brains from neuropathologically confirmed AD patients with a clinical diagnosis of either mild cognitive impairment (MCI) or dementia (n = 45) were compared with retinas from age- and sex-matched individuals with normal cognition (n = 30) and non-AD dementia (n = 4). Retinal tau isoforms, including tau tangles, paired helical filament of tau (PHF-tau), oligomeric-tau (Oligo-tau), hyperphosphorylated-tau (p-tau), and citrullinated-tau (Cit-tau), were stereologically analyzed by immunohistochemistry and Nanostring GeoMx digital spatial profiling, and correlated with clinical and neuropathological outcomes. Our data indicated significant increases in various AD-related pretangle tau isoforms, especially p-tau (AT8, 2.9-fold, pS396-tau, 2.6-fold), Cit-tau at arginine residue 209 (CitR209-tau; 4.1-fold), and Oligo-tau (T22+, 9.2-fold), as well as pretangle and mature tau tangle forms like MC-1-positive (1.8-fold) and PHF-tau (2.3-fold), in AD compared to control retinas. MCI retinas also exhibited substantial increases in Oligo-tau (5.2-fold), CitR209-tau (3.5-fold), and pS396-tau (2.2-fold). Nanostring GeoMx analysis confirmed elevated retinal p-tau at epitopes: Ser214 (2.3-fold), Ser396 (2.6-fold), Ser404 (2.4-fold), and Thr231 (1.8-fold), particularly in MCI patients. Strong associations were found between retinal tau isoforms versus brain pathology and cognitive status: a) retinal Oligo-tau vs. Braak stage, neurofibrillary tangles (NFTs), and CDR cognitive scores (ρ = 0.63–0.71), b) retinal PHF-tau vs. neuropil threads (NTs) and ABC scores (ρ = 0.69–0.71), and c) retinal pS396-tau vs. NTs, NFTs, and ABC scores (ρ = 0.67–0.74). Notably, retinal Oligo-tau strongly correlated with retinal Aβ42 and arterial Aβ40 forms (r = 0.76–0.86). Overall, this study identifies and quantifies diverse retinal tau isoforms in MCI and AD patients, underscoring their link to brain pathology and cognition. These findings advocate for further exploration of retinal tauopathy biomarkers to facilitate AD detection and monitoring via noninvasive retinal imaging.

Original languageEnglish
Article number3
JournalActa Neuropathologica
Volume148
Issue number1
DOIs
StatePublished - Dec 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Funding

Open access funding provided by SCELC, Statewide California Electronic Library Consortium. This work has been supported by the National Institutes of Health (NIH)/the National Institute on Aging (NIA) through the following grants: R01 AG055865 and R01 AG056478 (M.K.H.), the Alzheimer's Association Research Fellowship to Promote Diversity AARFD-21-851509 (H.S.), The Hertz Innovation Fund (M.K.H.), and the Gordon, Wilstein, and Saban Private Foundations (M.K.H.). M.D., O.J., and E.R. are supported by The Ray Charles Foundation. Additional support comes from the National Eye Institute (NEI) R01 EY013431 (A.V.L.) and the NIH P30 AG 066530 (D.H.) awards. We thank Elijiah Maxfield for assisting with manuscript editing. We also thank the Cedars-Sinai Medical Center Pathology and Imaging Core for their assistance with the GeoMx experiment. We acknowledge the contribution of Prof. Carol Ann Miller, the former director of the USC-ADRC neuropathology laboratory, for providing part of the neuropathological reports. The authors dedicate this manuscript to the memory of Dr. Salomon Moni Hamaoui and Lillian Jones Black, both of whom died from Alzheimer’s disease.

FundersFunder number
Ray Charles Foundation
Hertz Innovation Fund
Cedars-Sinai Medical Center
National Institutes of Health (NIH)
Saban Private Foundations
USC-ADRC
National Eye Institute (NEI)P30 AG 066530, R01 EY013431
National Institute on AgingR01 AG055865, R01 AG056478
Alzheimer's AssociationAARFD-21-851509

    Keywords

    • Dementia with Lewy bodies
    • Eye
    • Frontotemporal lobar dementia
    • Neurodegenerative diseases
    • Retinal biomarkers
    • Tauopathy

    ASJC Scopus subject areas

    • Pathology and Forensic Medicine
    • Clinical Neurology
    • Cellular and Molecular Neuroscience

    Fingerprint

    Dive into the research topics of 'Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status'. Together they form a unique fingerprint.

    Cite this